BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22474725)

  • 1. Depigmentation therapy for vitiligo in patients with Fitzpatrick skin type VI.
    Black W; Russell N; Cohen G
    Cutis; 2012 Feb; 89(2):57-60. PubMed ID: 22474725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo nonsurgical treatment: a review of latest treatment researches.
    Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
    Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
    Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
    Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depigmentation therapies in vitiligo.
    Gupta D; Kumari R; Thappa DM
    Indian J Dermatol Venereol Leprol; 2012; 78(1):49-58. PubMed ID: 22199060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.
    Njoo MD; Vodegel RM; Westerhof W
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):760-9. PubMed ID: 10775851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversial issues in vitiligo patients: a review of old and recent treatments.
    Lotti T; Gianfaldoni S; Valle Y; Rovesti M; Feliciano C; Satolli F
    Dermatol Ther; 2019 Jan; 32(1):e12745. PubMed ID: 30221810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo.
    Kenney JA
    Dermatol Clin; 1988 Jul; 6(3):425-34. PubMed ID: 3168334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study.
    van Geel N; Depaepe L; Speeckaert R
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1121-7. PubMed ID: 25286980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of localized, resistant, tingling vitiligo to pregabalin: A case report.
    Madura C; Harsha S; Kusuma MR; Chandrashekar BS
    Dermatol Ther; 2018 Nov; 31(6):e12702. PubMed ID: 30456812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depigmentation of the skin induced by 4-(4-hydroxyphenyl)-2-butanol is spontaneously re-pigmented in brown and black guinea pigs.
    Kuroda Y; Takahashi Y; Sakaguchi H; Matsunaga K; Suzuki T
    J Toxicol Sci; 2014 Aug; 39(4):615-23. PubMed ID: 25056786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole.
    Di Nuzzo S; Masotti A
    Clin Exp Dermatol; 2010 Mar; 35(2):215-6. PubMed ID: 20447090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo.
    Ezzedine K; Eleftheriadou V; Whitton M; van Geel N
    Lancet; 2015 Jul; 386(9988):74-84. PubMed ID: 25596811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of Hypopigmentation.
    Dina Y; McKesey J; Pandya AG
    J Drugs Dermatol; 2019 Mar; 18(3):s115-s116. PubMed ID: 30909355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo.
    Rao J; Fitzpatrick RE
    Dermatol Surg; 2004 Jul; 30(7):1043-5. PubMed ID: 15209798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
    Grau C; Silverberg NB
    Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of trichloroacetic acid as a depigmenting therapy in universal vitiligo.
    Nofal A; Fawzy MM; Alakad R
    J Dtsch Dermatol Ges; 2021 Feb; 19(2):241-246. PubMed ID: 33197126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.